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Aortoenteric fistula as a late complication of
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perioperative occlusion of aortofemoral bypass
Yamume Tshomba, MD, Andrea Kahlberg, MD, Enrico Maria Marone, MD, Francesco Setacci, MD,
Davide Logaldo, MD, and Roberto Chiesa, MD, Milan, Italy
We previously described the case of a 47-year-old man who experienced perioperative graft occlusion after infrarenal
aortic endarterectomy and aortobifemoral expanded polytetrafluoroethylene bypass graft for occlusive disease. The
patient was treated with local graft thrombolysis and stenting of an intimal flap at the level of the endarterectomized aorta
next to the aortic anastomosis. An urgent laparotomy performed 6 years later showed aortic wall perforation by the stent
with a large aortoenteric fistula. Surgical treatment included removal of the stent and the aortobifemoral graft, bowel
repair, and extra-anatomic lower-limb revascularization by axillofemoral and cross-femoral bypass grafting. The patient
was discharged 12 days later with no early complications. Although local thrombolysis and stenting may be a technically
feasible technique instead of reoperation in early aortofemoral graft thrombosis, long-term results of this procedure may
be affected by perigraft hematoma due to perioperative thrombolysis, increased risk of infection due to the prolonged
intragraft cannulation, and risk of stent-related aortic injury, especially if an endarterectomy has been performed. All
these issues may increase the risk of late aortoenteric fistula. More experience with hybrid, open/endovascular
procedures, and more contemporary stent-based devices is needed to assess the efficacy and safety of this alternative
treatment. (J Vasc Surg 2006;44:408-11.)During surgery for aortoiliac occlusive disease, early
postoperative aortofemoral bypass graft thrombosis is a
relatively unusual complication that is most often associ-
ated with technical issues, embolization, or hypercoagula-
bility disorders.1 Although surgical thrombectomy is con-
sidered standard treatment in these cases, an endovascular
approach to graft occlusion can be used to reduce the risk of
reoperation.2 Intra-arterial selective thrombolysis and
stenting have been previously reported to be feasible in
perioperative graft occlusion without significant early com-
plications, such as bleeding, from the recently scarred tis-
sues and the arterial anastomoses.2,3
Long-term results of this alternative technique have not
been reported, and the risk of late complications should be
carefully considered and reported in the literature. We
report a case of aortoenteric fistula that occurred 6 years
after a successful intra-arterial thrombolysis and aortic
stenting for perioperative occlusion of an aortofemoral
expanded polytetrafluoroethylene (ePTFE) bypass graft.
CASE REPORT
In 1999, a 47-year-old man underwent infrarenal circumfer-
ential aortic endarterectomy and aortobifemoral bypass graft (14
7 mm PTFE) with an end-to-side aortic anastomosis for occlusive
disease. Acute bilateral limb ischemia developed 18 hours after the
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408procedure. Color-flow duplex and emergent angiography, per-
formed through a left brachial approach, showed total occlusion of
the infrarenal aorta and massive thrombosis of the aortobifemoral
bypass graft.
Local thrombolysis with recombinant tissue plasminogen ac-
tivator was immediately begun through an infusion catheter ad-
vanced first to the right and then to the left limb of the graft. It was
continued for 12 hours for each limb of the graft at a rate of 1
mg/h. Intravenous heparin was also administrated at an infusion
rate of 500 U/h.
An angiogram performed 24 hours later showed recanaliza-
tion of the graft with complete dissolution of the thrombus.
Angiography also showed an infrarenal intimal aortic flap proximal
to the aortic anastomosis producing a 30 mm Hg gradient across
the lesion. This was treated in the interventional suite with a
Palmaz P4014 balloon-expandable stent implantation (Cordis En-
dovascular, Miami Lakes, Fla) through a percutaneous right axil-
lary access. The stent was correctly deployed in-line in the endar-
terectomized aorta, with partial covering of the anastomosis, and
was dilated using a 13-mm balloon. No complication occurred,
and the completion angiogram showed a good result. The patient
was discharged 7 days after the procedure with prescriptions for
ticlopidine (250 mg twice daily for 1 month) and aspirin (100
mg/d).
Color-flow duplex studies performed after 1 and 6 months,
and then yearly, revealed patency of the aortobifemoral bypass
graft without evidence of restenosis, narrowing, or pseudoaneu-
rysms. A 4-mm-thick perigraft fluid collection was assessed at the
first follow-up study and remained stable in all the following
examinations. This was thought to be the result of an expected
temporary small bleed during thrombolysis from the ePTFE graft
at the level of the recent aortic suture line. Because of the perigraft
fluid collection, the use of thrombolytic agents, and the aortic
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scan, but the patient never complied.
Six years after the procedure, the patient presented to our
department with fever, nausea, and abdominal pain that began 10
days previously. At admission, he was hemodynamically stable,
presenting with a fever of 38°C, mild leucocytosis (white blood cell
count of 10,300/mm3), and elevated markers of systemic inflam-
mation (C-reactive protein, 126.57 mg/L).
A CT scan of the abdomen revealed a 10-cm fluid collection
and air within it just next to the proximal anastomosis of the
aortobifemoral graft, where the Palmaz stent was deployed (Fig 1).
The last duplex study 8 months previously had revealed the well-
known, stable 4-mm perigraft collection with no signs of infection.
A perigraft infection was suspected, and polyantibiotic therapy
with vancomycin, metronidazole, and levofloxacin was started.
During the preoperative period, an episode of hematemesis
and melena was observed, thus the patient underwent urgent
laparotomy. Proximal aortic control was obtained at the suprace-
liac aorta, and after the clots and the fluid collection were evacu-
ated, a 2.5-cm fistula was identified between the aortic right lateral
wall at the level of the proximal anastomosis of the aortofemoral
graft and the third part of the duodenum (Fig 2). Apparently, the
anastomotic suture line was not damaged, but the stent had
perforated the right side of the aortic wall. The stent was removed,
the duodenal perforation was temporarily closed, and the aorto-
bifemoral graft was completely excised. The proximal and distal
aortic stumps were oversewn with a two-layer polypropylene su-
ture. After débridement of infected perigraft tissues and irrigation
with a solution of 0.5% rifamycin to reduce residual bacterial
contamination, we used a pedicle of omentum to cover the aortic
stumps. The abdomen was temporarily closed, and we sequentially
performed a right axillofemoral (8-mm supported PTFE) and
cross-femoral (8-mm supported PTFE) bypass graft.
At inspection, no fluid collections or other signs of infection
were found in the groins, and the new extra-anatomic grafts were
sutured to the native femoral arteries in the site of the previous
anastomoses. After the abdomen was reopened, the third part of
Fig 1. Computed tomography scan shows air bubbles within the
fluid collection (arrows) surrounding the proximal anastomosis of
the aortobifemoral graft where the Palmaz stent was deployed after
graft thrombolysis 6 years previously.the duodenum was resected and bowel continuity was restoredthrough a side-to-side duodenojejunal anastomosis. The retroperi-
toneum and the pouch of Douglas were drained for 48 hours.
Cultures from the purulent periaortic fluid grew multiple organ-
isms, including Bacteroides and yeast. Intravenous antibiotic ther-
apy with levofloxacin, clindamycin, and fluconazole was continued
for 6 weeks.
The postoperative course was uneventful, and the patient was
discharged to a rehabilitation facility after 12 days. Contrast CT
scans at 2 and 6 months after the operation did not show any
evidence of infection or periaortic collection. The patient remains
well at 10-months follow-up.
DISCUSSION
Secondary aortoenteric fistula occurring after prior aor-
tic surgery is an uncommon but catastrophic event with a
very high mortality in recent series.4 Reports have described
a 0.4% to 4% incidence of secondary aortoenteric fistula
after open abdominal aortic surgery.5 According to the
classification of Vollmar and Kogel,6 fistulas at the aortic
anastomosis may develop in the absence (type 1A) or
presence (type 1B) of an associated pseudoaneurysm, and
the etiology usually involves infection of the prosthesis,
local inflammatory changes, aortic wall rupture, and break-
down of the suture line. Moreover, continued pulsatile
pressure from a noncompliant prosthesis can lead to graft-
enteric erosion and fistulization, considered as subsequent
phases of the same pathologic process.7 Because of the long
time interval between aortic reconstruction and aortoen-
teric fistula formation, the cause of this complication is
usually difficult to establish.
We previously reported a case of acute thrombosis of
aortofemoral bypass graft in the same patient, treated with
regional thrombolysis followed by stenting of an infrarenal
aortic intimal flap with a Palmaz balloon-expandable stent.2
Fig 2. Intraoperative image details the stent within the infrarenal
aorta during excision of the proximal anastomosis of the aortob-
ifemoral bypass graft. After the clots and the fluid collection were
evacuated, a perforation by the stent of the aortic right lateral wall
and a large fistula with the third part of the duodenum were
assessed.We described this endovascular approach as a feasible alter-
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ity and amputation rates associated with surgical reopera-
tion,8 reducing operative risk.
We believe the life-threatening complication we ob-
served at the 6-year follow-up was partially related to the
inadequate materials available at the time of the procedure.
Now, we would consider the endovascular treatment we
performed and published in 2003 to be unsafe.2 We as-
sessed this case to be prone to all the main risk factors for
development of late aortoenteric fistula, related to the
aortic endarterectomy, the thrombolysis, and the aortic
stenting.
The complications associated with the use of thrombo-
lytic agents in a recent surgical field are well known and
mainly related to the risk of bleeding from the recently
scarred tissues and from the vascular anastomoses. This risk
may be only partially reduced by the use of local thrombol-
ysis instead of systemic administration. Owing to the pecu-
liarity of materials,9,10 suture-line bleeding is more fre-
quent with ePTFE grafts andmay be increased by the use of
thrombolytic agents.11 In this respect, early thrombolysis
could increase the risk of onset of perigraft hematoma and
pseudoaneurysm. As we know, both conditions are in-
volved in postoperative infection and aortoenteric fistula.12
Although we recognize that surgical thrombectomy
may reduce the risk of these complications, crossing an
aortic flap with a conventional thrombectomy catheter may
be technically demanding or lead to retrograde aortic dis-
section. The small perigraft fluid collection we assessed
postoperatively did not seem to be an aortic pseudoaneu-
rysm or active bleeding because of the absence of color-flow
signal at duplex scan. Despite that, we suggested a contrast
CT scan, which the patient, unfortunately, never had. This
study could have been more accurate in the characteriza-
tion of the fluid collection and in the later follow-up.
Several authors hypothesized that during aortic endo-
vascular repair, fistulas with surrounding structures may
arise secondary to the erosion of the metallic stent through
the aorta.4,13-16 In our case, graft thrombosis was caused
when we deployed a bare metal stent in a recently endar-
terectomized infrarenal aorta to correct the intimal flap
originating from an aortic endarterectomy. Specifically, the
mechanical features of the Palmaz stent render it inflexible
or stiff compared with other endovascular devices. This
could have increased the risk of aortoenteric fistula, espe-
cially considering that aortic endarterectomy is likely able
to create a weakened aortic wall more prone to develop
lesions, such as aortic perforation or pseudoaneurysm, if a
stent is immediately deployed. This may be due to the
decreased artery resistance to radial forces also described for
acute aortic dissection by Kato et al,17 who observed an
increased risk of development of saccular aneurysms after
stent-graft repair of acute aortic dissection.
In our case, we made an effort to limit the stress caused
by the radial force on the aortic suture line by avoiding a
stent that was oversized compared with the aortic diameter.
However, further evaluation should be required to assess
the safety of the stenting of friable, endarterectomizedarteries next to a recent vascular anastomotic suture line.
Accordingly, the choice to treat a perioperative intimal flap
with a balloon-expandable stent in these cases should be
carefully assessed. Currently, more flexible devices, such as
the last-generation self-expandable stents, should be pre-
ferred. In particular, covered stents (with metal within the
fabric to avoid direct contact with the arterial wall) or
investigational endografts recently proposed for the treat-
ment of acute aortic dissection may have an interesting
application in selected cases.
Finally, hybrid open and endovascular procedures are
known to have a higher rate of infective complications
compared with conventional open procedures, being more
complex, using multiple percutaneous accesses, and requir-
ing prolonged intra-arterial or intragraft cannulation.18 In
our case, however, the absence of signs of infection for 6
years and the presence of Bacteroides and yeast in the
periaortic fluid cultures make a gastrointestinal origin of the
infection more probable than a primitive infection of the
stent or graft, since the latter is usually sustained by gram-
positive organisms.
CONCLUSIONS
Our experience with this patient revealed how local
thrombolysis and stenting could be a feasible alternative to
reoperation for the treatment of perioperative abdominal
aortic graft thrombosis caused by intimal flap after aortic
endarterectomy. However, the risk factors for long-term
aortoenteric fistula development, such as perianastomotic
hematoma, the stenting of a recently endarterectomized
friable aortic wall, and the threat of infection due to pro-
longed intra-arterial cannulation during thrombolysis, are
significant in this alternative procedure. More experience
with hybrid open/endovascular procedures is necessary to
evaluate the real safety of this treatment, to determine
which kind of follow up is necessary, to schedule which kind
of endovascular materials must be used, and to understand
if some types of vascular grafts and sutures could be at
major risk for late aortoenteric fistula development if
thrombolysis and stenting are performed perioperatively.
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